The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Liver Cancer Therapeutics Market Research Report 2025
Synopsis
Liver cancer, also known as hepatic cancer and primary hepatic cancer, is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known as liver metastasis, is more common than that which starts in the liver. Symptoms of liver cancer may include a lump or pain in the right side below the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, and weakness. The treatment of liver cancer patients is mainly determined by the organ involved, the tumor spread, the patient's general condition and age.
The global Liver Cancer Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liver Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cancer Therapeutics.
Report Scope
The Liver Cancer Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liver Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liver Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ArQule
Bayer
Bristol-Myers Squibb
Celsion
Eisai
Exelixis
Roche
Merck
Pfizer
IntegraGen
Segment by Type
Targeted Therapy
Radiation Therapy
Immunotherapy
Chemotherapy
Other
Segment by Application
Hepatocellular Carcinoma
Cholangio Carcinoma
Hepatoblastoma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Cancer Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Liver cancer, also known as hepatic cancer and primary hepatic cancer, is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known as liver metastasis, is more common than that which starts in the liver. Symptoms of liver cancer may include a lump or pain in the right side below the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, and weakness. The treatment of liver cancer patients is mainly determined by the organ involved, the tumor spread, the patient's general condition and age.
The global Liver Cancer Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liver Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cancer Therapeutics.
Report Scope
The Liver Cancer Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liver Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liver Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ArQule
Bayer
Bristol-Myers Squibb
Celsion
Eisai
Exelixis
Roche
Merck
Pfizer
IntegraGen
Segment by Type
Targeted Therapy
Radiation Therapy
Immunotherapy
Chemotherapy
Other
Segment by Application
Hepatocellular Carcinoma
Cholangio Carcinoma
Hepatoblastoma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Cancer Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Cancer Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Targeted Therapy
1.2.3 Radiation Therapy
1.2.4 Immunotherapy
1.2.5 Chemotherapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Liver Cancer Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hepatocellular Carcinoma
1.3.3 Cholangio Carcinoma
1.3.4 Hepatoblastoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liver Cancer Therapeutics Market Perspective (2019-2030)
2.2 Liver Cancer Therapeutics Growth Trends by Region
2.2.1 Global Liver Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liver Cancer Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Liver Cancer Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Liver Cancer Therapeutics Market Dynamics
2.3.1 Liver Cancer Therapeutics Industry Trends
2.3.2 Liver Cancer Therapeutics Market Drivers
2.3.3 Liver Cancer Therapeutics Market Challenges
2.3.4 Liver Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Cancer Therapeutics Players by Revenue
3.1.1 Global Top Liver Cancer Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Liver Cancer Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Liver Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liver Cancer Therapeutics Revenue
3.4 Global Liver Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Liver Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Cancer Therapeutics Revenue in 2023
3.5 Liver Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Liver Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Liver Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Cancer Therapeutics Breakdown Data by Type
4.1 Global Liver Cancer Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Liver Cancer Therapeutics Forecasted Market Size by Type (2025-2030)
5 Liver Cancer Therapeutics Breakdown Data by Application
5.1 Global Liver Cancer Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Liver Cancer Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liver Cancer Therapeutics Market Size (2019-2030)
6.2 North America Liver Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Liver Cancer Therapeutics Market Size by Country (2019-2024)
6.4 North America Liver Cancer Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liver Cancer Therapeutics Market Size (2019-2030)
7.2 Europe Liver Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Liver Cancer Therapeutics Market Size by Country (2019-2024)
7.4 Europe Liver Cancer Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liver Cancer Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Liver Cancer Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Liver Cancer Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Liver Cancer Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liver Cancer Therapeutics Market Size (2019-2030)
9.2 Latin America Liver Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Liver Cancer Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Liver Cancer Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Cancer Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Liver Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Liver Cancer Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Liver Cancer Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ArQule
11.1.1 ArQule Company Detail
11.1.2 ArQule Business Overview
11.1.3 ArQule Liver Cancer Therapeutics Introduction
11.1.4 ArQule Revenue in Liver Cancer Therapeutics Business (2019-2024)
11.1.5 ArQule Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Liver Cancer Therapeutics Introduction
11.2.4 Bayer Revenue in Liver Cancer Therapeutics Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Liver Cancer Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Revenue in Liver Cancer Therapeutics Business (2019-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Celsion
11.4.1 Celsion Company Detail
11.4.2 Celsion Business Overview
11.4.3 Celsion Liver Cancer Therapeutics Introduction
11.4.4 Celsion Revenue in Liver Cancer Therapeutics Business (2019-2024)
11.4.5 Celsion Recent Development
11.5 Eisai
11.5.1 Eisai Company Detail
11.5.2 Eisai Business Overview
11.5.3 Eisai Liver Cancer Therapeutics Introduction
11.5.4 Eisai Revenue in Liver Cancer Therapeutics Business (2019-2024)
11.5.5 Eisai Recent Development
11.6 Exelixis
11.6.1 Exelixis Company Detail
11.6.2 Exelixis Business Overview
11.6.3 Exelixis Liver Cancer Therapeutics Introduction
11.6.4 Exelixis Revenue in Liver Cancer Therapeutics Business (2019-2024)
11.6.5 Exelixis Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Liver Cancer Therapeutics Introduction
11.7.4 Roche Revenue in Liver Cancer Therapeutics Business (2019-2024)
11.7.5 Roche Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Liver Cancer Therapeutics Introduction
11.8.4 Merck Revenue in Liver Cancer Therapeutics Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Liver Cancer Therapeutics Introduction
11.9.4 Pfizer Revenue in Liver Cancer Therapeutics Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 IntegraGen
11.10.1 IntegraGen Company Detail
11.10.2 IntegraGen Business Overview
11.10.3 IntegraGen Liver Cancer Therapeutics Introduction
11.10.4 IntegraGen Revenue in Liver Cancer Therapeutics Business (2019-2024)
11.10.5 IntegraGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Liver Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Other
Table 7. Global Liver Cancer Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Liver Cancer Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Liver Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Liver Cancer Therapeutics Market Share by Region (2019-2024)
Table 11. Global Liver Cancer Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Liver Cancer Therapeutics Market Share by Region (2025-2030)
Table 13. Liver Cancer Therapeutics Market Trends
Table 14. Liver Cancer Therapeutics Market Drivers
Table 15. Liver Cancer Therapeutics Market Challenges
Table 16. Liver Cancer Therapeutics Market Restraints
Table 17. Global Liver Cancer Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Liver Cancer Therapeutics Market Share by Players (2019-2024)
Table 19. Global Top Liver Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Therapeutics as of 2023)
Table 20. Ranking of Global Top Liver Cancer Therapeutics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Liver Cancer Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Liver Cancer Therapeutics Product Solution and Service
Table 24. Date of Enter into Liver Cancer Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Liver Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Liver Cancer Therapeutics Revenue Market Share by Type (2019-2024)
Table 28. Global Liver Cancer Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Liver Cancer Therapeutics Revenue Market Share by Type (2025-2030)
Table 30. Global Liver Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Liver Cancer Therapeutics Revenue Market Share by Application (2019-2024)
Table 32. Global Liver Cancer Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Liver Cancer Therapeutics Revenue Market Share by Application (2025-2030)
Table 34. North America Liver Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Liver Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Liver Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Liver Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Liver Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Liver Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Liver Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Liver Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Liver Cancer Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Liver Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Liver Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Liver Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Liver Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Liver Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Liver Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 49. ArQule Company Detail
Table 50. ArQule Business Overview
Table 51. ArQule Liver Cancer Therapeutics Product
Table 52. ArQule Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 53. ArQule Recent Development
Table 54. Bayer Company Detail
Table 55. Bayer Business Overview
Table 56. Bayer Liver Cancer Therapeutics Product
Table 57. Bayer Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 58. Bayer Recent Development
Table 59. Bristol-Myers Squibb Company Detail
Table 60. Bristol-Myers Squibb Business Overview
Table 61. Bristol-Myers Squibb Liver Cancer Therapeutics Product
Table 62. Bristol-Myers Squibb Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 63. Bristol-Myers Squibb Recent Development
Table 64. Celsion Company Detail
Table 65. Celsion Business Overview
Table 66. Celsion Liver Cancer Therapeutics Product
Table 67. Celsion Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 68. Celsion Recent Development
Table 69. Eisai Company Detail
Table 70. Eisai Business Overview
Table 71. Eisai Liver Cancer Therapeutics Product
Table 72. Eisai Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 73. Eisai Recent Development
Table 74. Exelixis Company Detail
Table 75. Exelixis Business Overview
Table 76. Exelixis Liver Cancer Therapeutics Product
Table 77. Exelixis Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 78. Exelixis Recent Development
Table 79. Roche Company Detail
Table 80. Roche Business Overview
Table 81. Roche Liver Cancer Therapeutics Product
Table 82. Roche Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 83. Roche Recent Development
Table 84. Merck Company Detail
Table 85. Merck Business Overview
Table 86. Merck Liver Cancer Therapeutics Product
Table 87. Merck Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Pfizer Company Detail
Table 90. Pfizer Business Overview
Table 91. Pfizer Liver Cancer Therapeutics Product
Table 92. Pfizer Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. IntegraGen Company Detail
Table 95. IntegraGen Business Overview
Table 96. IntegraGen Liver Cancer Therapeutics Product
Table 97. IntegraGen Revenue in Liver Cancer Therapeutics Business (2019-2024) & (US$ Million)
Table 98. IntegraGen Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Cancer Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Liver Cancer Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Targeted Therapy Features
Figure 4. Radiation Therapy Features
Figure 5. Immunotherapy Features
Figure 6. Chemotherapy Features
Figure 7. Other Features
Figure 8. Global Liver Cancer Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Liver Cancer Therapeutics Market Share by Application: 2023 VS 2030
Figure 10. Hepatocellular Carcinoma Case Studies
Figure 11. Cholangio Carcinoma Case Studies
Figure 12. Hepatoblastoma Case Studies
Figure 13. Other Case Studies
Figure 14. Liver Cancer Therapeutics Report Years Considered
Figure 15. Global Liver Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Liver Cancer Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Liver Cancer Therapeutics Market Share by Region: 2023 VS 2030
Figure 18. Global Liver Cancer Therapeutics Market Share by Players in 2023
Figure 19. Global Top Liver Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Therapeutics as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Liver Cancer Therapeutics Revenue in 2023
Figure 21. North America Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Liver Cancer Therapeutics Market Share by Country (2019-2030)
Figure 23. United States Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Liver Cancer Therapeutics Market Share by Country (2019-2030)
Figure 27. Germany Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Liver Cancer Therapeutics Market Share by Region (2019-2030)
Figure 35. China Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Liver Cancer Therapeutics Market Share by Country (2019-2030)
Figure 43. Mexico Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Liver Cancer Therapeutics Market Share by Country (2019-2030)
Figure 47. Turkey Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Liver Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. ArQule Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)
Figure 50. Bayer Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)
Figure 52. Celsion Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)
Figure 53. Eisai Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)
Figure 54. Exelixis Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)
Figure 55. Roche Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)
Figure 57. Pfizer Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)
Figure 58. IntegraGen Revenue Growth Rate in Liver Cancer Therapeutics Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
